secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001420720-22-000094
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio prices $3.5M underwritten public offering of common stock and warrants
---------------------------------------------------------------------------

- Offering includes 3,365,385 shares (or pre-funded warrants) and Series A/B warrants with $1.04 exercise price.
- Net proceeds to the company are approximately $2.9 million, used for operating costs, R&D, working capital, and debt payments.
- Closing expected on or about December 9, 2022, subject to customary conditions. H.C. Wainwright is sole book-runner.
- Underwriter granted 30-day option to purchase up to an additional 504,807 shares and/or warrants.
- Representative’s Warrants issued to purchase 6% of offering shares at $1.30 exercise price, 5-year term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000094/0001420720-22-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072022000094/ibio-20221206x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-22-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer